Literature DB >> 21835252

Magnetic resonance imaging of the mouse visual pathway for in vivo studies of degeneration and regeneration in the CNS.

Ronny Haenold1, Karl-Heinz Herrmann, Silvio Schmidt, Jürgen R Reichenbach, Karl-Friedrich Schmidt, Siegrid Löwel, Otto W Witte, Falk Weih, Alexandra Kretz.   

Abstract

Traditionally, depiction of isolated CNS fiber tracts is achieved by histological post mortem studies. As a tracer-dependent strategy, the calcium analog manganese has proved valuable for in vivo imaging of CNS trajectories, particularly in rats. However, adequate protocols in mice are still rare. To take advantage of the numerous genetic mouse mutants that are available to study axonal de- and regeneration processes, a MnCl2-based protocol for high-resolution contrast-enhanced MRI (MEMRI) of the visual pathway in mice acquired on a widely used clinical 3 Tesla scanner was established. Intravitreal application of MnCl2 significantly enhanced T1-weighted contrast and signal intensity along the retino-petal projection enabling its reconstruction in a 3D mode from a maximum intensity projection (MIP) calculated dataset. In response to crush injury of the optic nerve, axonal transport of MnCl2 was diminished and completely blocked proximal and distal to the lesion site, respectively. Conditions of Wallerian degeneration after acute optic nerve injury accelerated Mn2+-enhanced signal fading in axotomized projection areas between 12 and 24 h post-injury. In long-term regeneration studies 12 months after optic nerve injury, the MRI protocol proved highly sensitive and discriminated animals with rare spontaneous axonal regrowth from non-regenerating specimens. Also, structural MRI aspects shared high correlation with histological results in identical animals. Moreover, in a model of chronic neurodegeneration in p50/NF-κB-deficient mice, MnCl2-based neuron-axonal tracing supported by heat map imaging indicated neuropathy of the visual pathway due to atrophy of optic nerve fiber projections. Toxic effects of MnCl2 at MRI contrast-relevant dosages in repetitive administration protocols were ruled out by histological and optometric examinations. At higher dosages, photoreceptors, not retinal ganglion cells, turned out as most susceptible to the well-known toxicity of MnCl2. Our data accentuate in vivo MEMRI of the murine visual system as a highly specific and sensitive strategy to uncover axonal degeneration and restoration processes, even in a functional latent state. We expect MEMRI to be promising for future applications in longitudinal studies on development, aging, or regeneration of CNS projections in mouse models mimicking human CNS pathologies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835252     DOI: 10.1016/j.neuroimage.2011.07.069

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  12 in total

1.  Possibilities and limitations for high resolution small animal MRI on a clinical whole-body 3T scanner.

Authors:  Karl-Heinz Herrmann; Silvio Schmidt; Alexandra Kretz; Ronny Haenold; Ines Krumbein; Martin Metzler; Christian Gaser; Otto W Witte; Jürgen R Reichenbach
Journal:  MAGMA       Date:  2011-10-22       Impact factor: 2.310

2.  Impact of repeated topical-loaded manganese-enhanced MRI on the mouse visual system.

Authors:  Shu-Wei Sun; Tiffany Thiel; Hsiao-Fang Liang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-12       Impact factor: 4.799

3.  In vivo MRI evaluation of anterograde manganese transport along the visual pathway following whole eye transplantation.

Authors:  Chiaki Komatsu; Yolandi van der Merwe; Lin He; Anisha Kasi; Jeffrey R Sims; Maxine R Miller; Ian A Rosner; Neil J Khatter; An-Jey A Su; Joel S Schuman; Kia M Washington; Kevin C Chan
Journal:  J Neurosci Methods       Date:  2022-02-22       Impact factor: 2.390

4.  Manganese-enhanced MRI (MEMRI) via topical loading of Mn(2+) significantly impairs mouse visual acuity: a comparison with intravitreal injection.

Authors:  Tsen-Hsuan Lin; Chia-Wen Chiang; Kathryn Trinkaus; William M Spees; Peng Sun; Sheng-Kwei Song
Journal:  NMR Biomed       Date:  2014-01-16       Impact factor: 4.044

5.  Axonal transport rate decreased at the onset of optic neuritis in EAE mice.

Authors:  Tsen-Hsuan Lin; Joong Hee Kim; Carlos Perez-Torres; Chia-Wen Chiang; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song
Journal:  Neuroimage       Date:  2014-06-14       Impact factor: 6.556

6.  In vivo imaging of optic nerve fiber integrity by contrast-enhanced MRI in mice.

Authors:  Stefanie Fischer; Christian Engelmann; Karl-Heinz Herrmann; Jürgen R Reichenbach; Otto W Witte; Falk Weih; Alexandra Kretz; Ronny Haenold
Journal:  J Vis Exp       Date:  2014-07-22       Impact factor: 1.355

7.  Improved visualization of neuronal injury following glial activation by manganese enhanced MRI.

Authors:  Aditya N Bade; Biyun Zhou; Adrian A Epstein; Santhi Gorantla; Larisa Y Poluektova; Jiangtao Luo; Howard E Gendelman; Michael D Boska; Yutong Liu
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-01       Impact factor: 4.147

8.  Quantification of retrograde axonal transport in the rat optic nerve by fluorogold spectrometry.

Authors:  Christian van Oterendorp; Stavros Sgouris; Michael Bach; Gottfried Martin; Julia Biermann; Jens F Jordan; Wolf A Lagrèze
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

Review 9.  Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases.

Authors:  Louise A Mesentier-Louro; Camila Zaverucha-do-Valle; Paulo H Rosado-de-Castro; Almir J Silva-Junior; Pedro M Pimentel-Coelho; Rosalia Mendez-Otero; Marcelo F Santiago
Journal:  Stem Cells Int       Date:  2015-11-16       Impact factor: 5.443

10.  Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration.

Authors:  Yao Chen; Chun-Yan Shi; Ying Li; Yun-Tao Hu; Hong-Bin Han; Xiao-Dong Sun; Satyajeet S Salvi; Zhi-Zhong Ma
Journal:  Chin Med J (Engl)       Date:  2016-08-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.